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. Cell-based studies showed that mTORC1 senses amino acids through the RagA-D family of GTPases 2, 3 (also known as RRAGA, B, C and D), but their importance in mammalian physiology is unknown. Here we generate knock-in mice that express a constitutively active form of RagA (RagA GTP ) from its endogenous promoter. RagA GTP/GTP mice develop normally, but fail to survive postnatal day 1. When delivered by Caesarean section, fasted RagA GTP/GTP neonates die almost twice as rapidly as wild-type littermates. Within an hour of birth, wild-type neonates strongly inhibit mTORC1, which coincides with profound hypoglycaemia and a decrease in plasma amino-acid concentrations. In contrast, mTORC1 inhibition does not occur in RagA GTP/GTP neonates, despite identical reductions in blood nutrient amounts. With prolonged fasting, wild-type neonates recover their plasma glucose concentrations, but RagA GTP/GTP mice remain hypoglycaemic until death, despite using glycogen at a faster rate. The glucose homeostasis defect correlates with the inability of fasted RagA GTP/GTP neonates to trigger autophagy and produce amino acids for de novo glucose production. Because profound hypoglycaemia does not inhibit mTORC1 in RagA GTP/GTP neonates, we considered the possibility that the Rag pathway signals glucose as well as amino-acid sufficiency to mTORC1. Indeed, mTORC1 is resistant to glucose deprivation in RagA GTP/GTP fibroblasts, and glucose, like amino acids, controls its recruitment to the lysosomal surface, the site of mTORC1 activation. Thus, the Rag GTPases signal glucose and amino-acid concentrations to mTORC1, and have an unexpectedly key role in neonates in autophagy induction and thus nutrient homeostasis and viability.
The mechanistic target of rapamycin (mTOR) is a serine-threonine kinase that as part of mTORC1 regulates anabolic and catabolic processes required for cell growth and proliferation 1 . mTORC1 integrates signals that reflect the nutritional status of an organism and senses growth factors and nutrients through distinct mechanisms. Growth factors regulate mTORC1 through the PI3K/Akt/TSC1-TSC2 axis, whereas amino acids act through the Rag family of GTPases 2, 3 . When activated, these GTPases recruit mTORC1 to the lysosomal surface, an essential step in mTORC1 activation 3, 4 . Amino-acid concentrations regulate nucleotide binding to the Rag GTPases in a Ragulator-and vacuolar-type H 1 -ATPase-dependent manner 4, 5 . In the absence of amino acids, RagA (or RagB, which acts in an identical manner) is loaded with GDP, but becomes bound to GTP when amino acids are plentiful.
To study the physiological importance of the amino-acid-dependent activation of mTORC1, we generated knock-in mice that expressed a constitutively active form of RagA. We chose to manipulate RagA because, although highly similar to RagB, RagA is much more abundant and widely expressed than RagB in mice ( Supplementary Fig. 1a) .
By a single nucleotide substitution in the RagA coding sequence, we replaced glutamine in position 66 with leucine, generating a RagA mutant (RagA Q66L ) ( Supplementary Fig. 1b ) that was, regardless of amino-acid concentrations, constitutively active, mimicking a permanent GTP-bound state 3, 6 (hereafter referred to as RagA GTP ). We obtained mouse embryo fibroblasts (MEFs) from embryonic day (E)13.5 embryos and evaluated mTORC1 signalling upon amino-acid or serum deprivation. In RagA 1/1 and RagA GTP/1 cells, deprivation of either amino acids (Fig. 1a) or serum ( Supplementary Fig. 1c ) suppressed mTORC1 activity, as determined by phosphorylation state of the mTORC1 substrates S6K1 and 4E-BP1. In contrast, in RagA GTP/GTP cells, mTORC1 activity was completely resistant to amino-acid withdrawal (Fig. 1a) . However, regulation of PI3K activity by serum was intact, as reflected by Akt phosphorylation (Supplementary Fig. 1c ). Interestingly, RagA protein was reduced in RagA GTP/GTP cells, but this was not a consequence of lower RagA GTP messenger (mRNA) expression (Fig. 1b) , supporting the existence of a negative feedback triggered by RagA activity. Nevertheless, the cells show the expected aminoacid-independent activation of mTORC1.
Cells lacking the TSC1-TSC2 tumour suppressor complex also have deregulated mTORC1 activity, as such cells maintain mTORC1 signalling in the absence of growth factors 1 . Unlike TSC1-or TSC2-deficient MEFs 7, 8 , RagA GTP/GTP MEFs have normal proliferation rates without accelerated senescence ( Supplementary Fig. 1d ). Furthermore, unlike TSC1-or TSC2-deficient embryos, which die at E11.5-E13.5, RagA GTP/GTP embryos were indistinguishable from RagA 1/1 embryos ( Supplementary Fig. 1e ), and fetuses were obtained and genotyped at term with the expected Mendelian ratios from heterozygous crosses. Thus, unlike with growth factor sensing, the inability of mTORC1 to sense amino-acid deprivation does not compromise survival during embryonic development, with its steady placental supply of nutrients.
Although apparently not deleterious during in utero development, constitutive RagA activity greatly impairs early postnatal survival. Heterozygous RagA GTP/1 mice did not have any obvious phenotypic alteration, in agreement with the normal signalling observed in RagA GTP/1 MEFs. However, no RagA GTP/GTP mice were obtained at weaning, and were usually found dead within 1 day postpartum in breeding cages. Neonatal death can stem from a variety of defects, so we obtained full-term E19.5 mice by Caesarean section and monitored them outside the breeding cage. Despite having a mild decrease in weight, RagA GTP/GTP neonates were barely distinguishable from control littermates (Fig. 1c, d ), and histological analyses showed no abnormalities ( Supplementary Fig. 1f ).
To understand how constitutive RagA activity affects the regulation of mTORC1 by fasting, we compared the phosphorylation of S6 and 4E-BP1, established markers of mTORC1 activity, in tissues obtained from neonates at birth or fasted for 1 or 10 h. Interestingly, just 1 h of fasting was sufficient to inhibit mTORC1 strongly in Fig. 1g) ; this difference persisted even after 10 h of fasting ( Fig. 1f and Supplementary Fig. 1h ). In contrast, Akt phosphorylation was modest at birth and decreased in mice of all genotypes (Supplementary Fig. 1g ). As in MEFs, RagA protein was reduced in the tissues of RagA GTP/GTP mice, but this again was not due to reduced mRNA levels ( Supplementary Fig. 1i ). Collectively, these results indicate that constitutive RagA activity causes a profound defect in the response of mTORC1 to fasting.
To examine the consequences of this defect, we fasted neonates for longer periods, which showed that RagA GTP/GTP neonates have an ) (Fig. 1g ). This was not the consequence of unappreciated developmental defects, as the treatment of pups at birth with the mTORC1 inhibitor rapamycin, which suppressed mTORC1 activity in all neonates (Supplementary Fig. 1j) , significantly delayed the death of fasted RagA
GTP/GTP
neonates from approximately 14 h to 21 h; P , 0.01) (Fig. 1h) . These data suggest that Rag-mediated regulation of mTORC1 is necessary for mice to adapt to and survive the starvation period that they endure between birth and feeding.
Consistent with this notion, analysis of blood glucose concentrations showed that fasted RagA GTP/GTP neonates suffer a profound defect in nutrient homeostasis. After 1 h of fasting, glycaemia dropped markedly in all neonates to below our 10 mg dl 21 limit of detection (Fig. 2a) , but by 3-6 h the wild-type animals restored their blood glucose to near birth levels (approximately 40 mg dl 21 ). In sharp contrast, in RagA GTP/GTP neonates, blood glucose concentrations never Amino acids: 
RagA
GTP/1 and RagA GTP/GTP neonates. Scale bar, 1 cm. e, Early suppression of mTORC1 signalling after birth was determined by immunoblotting of protein extracts from liver and heart of RagA 1/1 (1/1), RagA GTP/1 (G/1) and RagA GTP/GTP (G/G) neonates immediately after Caesarean section (0 h) or after 1 h of fasting (1 h fast). f, Liver and heart extracts from RagA
and RagA GTP/GTP neonates fasted for 10 h were analysed by immunoblotting for the indicated proteins. g, Survival curve of fasted neonates. Neonates obtained by Caesarean section and resuscitated were fasted and their survival monitored (1/1: n 5 13; G/1: n 5 26; G/G: n 5 10). h, Survival curve of fasted neonates treated with rapamycin. Neonates obtained by Caesarean section and resuscitated were fasted and their survival monitored (1/1: n 5 13; G/1: n 5 13; G/G: n 5 6). Numbers indicate the median survival for each curve. *P , 0.05; **P , 0.01; ***P , 0.005. (Fig. 2a) . Consistent with its rescue of the accelerated lethality of the RagA GTP/GTP neonates during fasting (Fig. 1h) , rapamycin administration partly reversed their defect in blood glucose concentrations (Fig. 2b) . Moreover, injections of glucose prolonged the lifespan of fasted RagA GTP/GTP mice (Fig. 2c) , arguing that a lack of glucose has a causal role in their compromised survival.
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Because the inability to generate glucose from glycogen can cause perinatal lethality 9 , we initially proposed that the RagA GTP/GTP neonates had a glycogen metabolism defect. However, RagA GTP/GTP neonates did not have defects in the protein or mRNA levels of the key enzymes of glycogen metabolism (Fig. 2d and Supplementary Fig. 2a) . Moreover, at birth RagA GTP/GTP neonates had normal amounts of hepatic glycogen, which, upon fasting, they consumed at a faster rate than RagA 1/1 and RagA GTP/1 animals (Fig. 2e) , suggesting not a defect in its breakdown but rather accelerated use secondary to hypoglycaemia. As with other characteristics of RagA GTP/GTP mice, rapamycin administration partly restored their hepatic glycogen (Fig. 2f) .
We also considered defects in gluconeogenesis or the availability of gluconeogenic substrates as potential reasons for the inability of RagA GTP/GTP neonates to restore blood glucose concentrations upon fasting. Here too the RagA GTP/GTP neonates did not have aberrations in the expression levels of the relevant enzymes (Fig. 2d) . However, after a fast for 10 h, RagA GTP/GTP neonates did have significantly lower levels of plasma amino acids compared with RagA 1/1 and RagA GTP/1 littermates ( Fig. 2g and Supplementary Fig. 2b ). Because murine neonates are born without significant fat stores 10 , lipid mobilization cannot serve as a substrate for de novo glucose production. Moreover, lactate, another substrate for gluconeogenesis, was not reduced in RagA GTP/GTP neonates ( Supplementary Fig. 2c ), arguing for a specific reduction in amino-acid substrates. As with glucose amounts and glycogen stores (Fig. 2b, f) , rapamycin administration reversed the decrease in aminoacid concentrations in RagA GTP/GTP neonates (Fig. 2g) . Furthermore, injection of a mix of gluconeogenic amino acids, which can contribute to gluconeogenesis but not protein synthesis, delayed the onset of death of RagA GTP/GTP neonates (Fig. 2h) , and injection of just alanine to fasted neonates provoked a significant increase in glycaemia (Supplementary Fig. 2d ). These data are consistent with the glucose homeostasis defect of the fasted RagA GTP/GTP neonates being a consequence of reduced circulating amino acids, which leads to lower de novo glucose production and plasma levels, and accelerated death.
Several properties of the RagA GTP/GTP mice are reminiscent of autophagy-deficient mice 11, 12 , including the reduction in plasma amino acids and lifespan upon fasting, as well as the slightly lower birth weight. Although mTORC1 negatively regulates autophagy 13 , and amino-acid concentrations are regulators of autophagy in rats 14 , many mTORC1-dependent and mTORC1-independent autophagy regulators exist 15 . Hence, we wondered if perturbing just one of the several inputs to mTORC1 could exert a dominant effect in the physiological regulation of autophagy.
Quantitative electron microscopy of livers from RagA 1/1 neonates fasted for 1 h showed abundant autophagosomes, characterized by double limiting membranes ( Fig. 3a and Supplementary Fig. 3a) . Autophagosomes rapidly mature into single-membrane autophagolysosomes, so these were also found in RagA 1/1 livers ( Fig. 3a and Supplementary Fig. 3a) , albeit the ratio of autophagosomes to autophagolysosomes was high. Both autophagic vacuoles were rarely observed in fasted RagA GTP/GTP littermates (Fig. 3a) . Similar results were obtained when skeletal muscle was analysed (Fig. 3a) .
Even after 10 h of fasting, the autophagy defect in the livers of RagA GTP/GTP neonates persisted, as detected by the reduced cleavage of LC3B and degradation of p62 (Fig. 3b) , which was increased by administration of rapamycin ( Supplementary Fig. 3b ). Biochemical analyses for these markers in skeletal and cardiac muscles from RagA GTP/GTP neonates after 1 and 2 h of fasting were also consistent with impaired autophagy (Fig. 3c) . Cells in culture mirrored the in vivo findings (Fig. 3d) , and these results were confirmed by detection of LC3B localization using fluorescence microscopy in aminoacid-starved cells (Fig. 3e and Supplementary Fig. 3c ). Consistently, phosphorylation of the autophagy activator ULK-1, a direct substrate of mTORC1 that was suppressed in RagA 1/1 MEFs upon amino-acid withdrawal, remained high in RagA GTP/GTP cells (Fig. 3d) . In addition, we looked at the transcription factor TFEB, which upregulates genes involved in lysosomal biogenesis and autophagy, but is excluded from the nucleus when phosphorylated by mTORC1 (refs 16, 17) . Upon amino-acid deprivation, TFEB localized to the nuclei of RagA 1/1 but not RagA GTP/GTP MEFs ( Fig. 3f and Supplementary Fig. 3d ). This result was mirrored by the decreased expression of TFEB transcriptional targets (Supplementary Fig. 3d) .
Serum withdrawal, which inhibits mTORC1 in a Rag-independent fashion, suppressed mTORC1 activity and triggered autophagy in MEFs of all genotypes (Supplementary Fig. 3e ), indicating that constitutive GTP/GTP neonates. b, Protein extracts from livers of neonates at Caesarean section (0 h) and fasted for 10 h were immunoblotted for autophagy markers LC3B and p62. c, Protein extracts from skeletal muscle and heart from neonates at Caesarean section (0 h), fasted for 1 and 2 h, were immunoblotted for indicated proteins. d, Triggering of autophagy by amino-acid withdrawal in MEFs. MEFs were deprived of amino acids for the indicated time points, whole-cell protein extracts were obtained and mTORC1 activity and autophagic activity determined by immunoblotting. e, Recombinant LC3B-GFP was expressed in RagA 1/1 and RagA GTP/GTP MEFs and LC3B localization, in the presence and absence of amino acids, monitored by fluorescence microscopy. LC3B-GFP (green fluorescent protein) clustering, indicative of autophagy, was observed in amino acid-starved RagA 1/1 but not RagA GTP/GTP MEFs. Scale bar, 10 mm. f, Localization of recombinant TFEB-GFP was determined in MEFs as in e. Nuclear (active) TFEB was observed in RagA 1/1 MEFs upon amino-acid withdrawal.
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RagA activity does not block autophagy induction by all signals. Thus, despite the multitude of pathways that regulate autophagy 15 , Rag GTPase activity upstream of mTORC1 is a major regulator of autophagy in vivo during the perinatal period.
Maintenance of mTORC1 activity requires the simultaneous presence of growth factors, amino acids and glucose 1 . We found that after just 1 h of fasting, both plasma amino-acid and glucose concentrations were reduced in neonates of all genotypes (Fig. 2a and Supplementary  Fig. 4a ). The drop in nutrients correlated with a strong inhibition of mTORC1 activity in RagA 1/1 and RagA
, but not RagA GTP/GTP , neonates (Fig. 1e) . Thus, despite a profound hypoglycaemic state, mTORC1 activity remained high in fasted RagA GTP/GTP neonates, a puzzling result given that the Rag GTPases are thought to have a specialized role in amino-acid sensing. These observations led us to consider that the Rag GTPases participate in the direct sensing of glucose concentrations, in addition to their established role in aminoacid sensing. A well-established link between low glucose (but not amino acids (Supplementary Fig. 4b) ) and mTORC1 inhibition is the AMP-activated protein kinase (AMPK). However, in MEFs lacking AMPK-a1 and -a2 (AMPK-DKO), mTORC1 activity was still repressed upon glucose deprivation, albeit less prominently than in wild-type MEFs (Fig. 4a) . This indicates that an AMPK-independent pathway of mTORC1 inhibition exists, as shown recently in the context of metformin treatment 18 . Compared with control cells, mTORC1 signalling was largely resistant to glucose deprivation in RagA GTP/GTP MEFs ( Fig. 4b and Supplementary Fig. 4c, e) and HEK-293T cells expressing RagB GTP ( Supplementary Fig. 4d, e) . It is unlikely that glucose indirectly inhibits mTORC1 by preventing amino-acid transport, because amino-acid esters, which freely enter cells and substitute for native amino acids in mTORC1 activation 5 , did not substitute for glucose (Supplementary Fig. 4f ). Moreover, intracellular amino-acid concentrations were only marginally affected in cells deprived of glucose ( Supplementary Fig. 4g ). In addition, like AMPK-deficient cells 19, 20 , RagA GTP/GTP cells had enhanced sensitivity to long-term In HEK-293T cells, glucose deprivation causes mTOR to localize to diffuse small puncta throughout the cytoplasm. Re-addition of glucose leads to mTOR shuttling to the lysosomal surface, co-localizing with the lysosomal protein Lamp2. HEK-293T-RagB GTP cells show mTOR localized at the lysosomal surface, regardless of glucose concentrations. Scale bars, 10 mm. e, Glucose and amino acids affect the binding of the v-ATPase to the Ragulator complex. HEK-293T expressing Flag-p14 was deprived of glucose or amino acids for 90 min and re-stimulated for 20 min. Protein extracts and immunoprecipitates were immunoblotted for the indicated proteins. f, RagA 1/1 and RagA GTP/GTP primary MEFs were cultured for 1 h in media with the glucose and amino-acid concentrations measured in neonates at birth (0 h) or after fasting for 1 h (1 h) and whole-cell protein extracts were analysed by immunoblotting. g, Proposed model for constitutive RagA-induced neonatal lethality. Green and red boxes indicate active and inactive protein or process, respectively.
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glucose-deprivation-induced death (Fig. 4c) . Constitutive RagA activity does not block AMPK action as aminoimidazole carboxamide ribonucleotide (AICAR), an AMPK activator, inhibited mTORC1 in cells of all genotypes (Supplementary Fig. 4h ). In addition, AMPK activity, as monitored by acetyl-CoA carboxylase phosphorylation, was induced to similar amounts in glucose-deprived RagA 1/1 and RagA GTP/GTP cells ( Fig. 4b and Supplementary Fig. 4c ), but absent in AMPK-null cells (Fig. 4a) . Another cellular nutrient sensor is GCN2 (ref. 21 ), but although it was regulated by amino acids, it was not by glucose; also, loss of GCN2 did not affect the inhibition of mTORC1 caused by aminoacid or glucose starvation (Supplementary Fig. 4i ). Amino acids promote the Rag-dependent translocation of mTORC1 to the lysosomal surface, a necessary event for its activation 4 . Interestingly, glucose deprivation, like that of amino acids ( Supplementary  Fig. 4j ), rendered mTORC1 diffusely localized in the cytoplasm of HEK-293T cells and, within minutes of glucose re-addition, mTORC1 re-clustered at lysosomes (Fig. 4d) . However, in HEK-293T cells expressing RagB GTP and in RagA GTP/GTP MEFs, mTORC1 localized at the lysosomal surface regardless of glucose concentrations (Fig. 4d and Supplementary Fig. 4k ). The lysosomal v-ATPase, necessary for the Rag-dependent activation of mTORC1 by amino acids, engages in amino-acid-sensitive interactions with the Ragulator 5 , and we found that glucose also regulates the binding of the v-ATPase to Ragulator (Fig. 4e) , suggesting a shared regulatory mechanism. Finally, when amino-acid and glucose concentrations at birth and after 1 h neonatal fasting were reproduced in the in vitro culture medium, mTORC1 activity was suppressed in RagA 1/1 but not in RagA GTP/GTP cells placed under the 1 h fasting conditions (Fig. 4f) . Hence, we propose that the Rag GTPases are a 'multi-input nutrient sensor', upon which amino acids and glucose converge, in a v-ATPase-dependent manner, upstream of mTORC1.
Altogether, our results support a chain of events that start with the interruption of maternal nutrient supply at birth, which inhibits mTORC1 presumably by converging negative inputs from profound hypoglycaemia and a drop in plasma amino acids, in a Rag-dependent fashion. During the period between birth and suckling, mTORC1 inhibition triggers autophagy, which generates the amino acids used to sustain plasma glucose concentrations through gluconeogenesis. Constitutive RagA activity prevents mTORC1 inhibition, leading to defective autophagy and, thus, insufficient amino-acid production. The lower levels of gluconeogenic amino acids reduce hepatic generation of glucose, which accelerated glycogen breakdown fails to compensate, ultimately leading to hypoglycaemia, energetic exhaustion and accelerated neonatal death (Fig. 4g) . Thus, the Rag GTPases have a critical role in nutrient sensing by mTORC1 and in neonatal survival during fasting.
METHODS SUMMARY
All animal studies and procedures were approved by the Massachusetts Institute of Technology Institutional Animal Care and Use Committee. To target the RagA locus, we generated a construct consisting of a transcriptional STOP cassette containing the hygromycin resistance gene, flanked by loxP sites (loxP-PGK-Hyg-STOP-loxP) 22 and placed at 59 of the RagA exon. A RagA activating mutation (Q66L) was generated by an A-to-T substitution in position 1197 in the RagA exon by site-directed mutagenesis. Chimaeras were crossed to CMVCre transgenic mice to allow expression of the RagA Q66L allele. Neonates were obtained by Caesarean section and placed in a humidified chamber at 30 uC and fasted. Subcutaneous injections of rapamycin were performed after Caesarean section, and those of glucose or a mix of gluconeogenic amino acids were performed after Caesarean section and at 3-6 h intervals. Neonatal plasma amino acids were quantified with an Acquity UPLC system (Waters), and hepatic glycogen content as described 23 . For statistical analyses, a log-rank Mantel-Cox method was used for Kaplan-Meier survival curves, and non-parametric t-tests and 2 3 2 x 2 tests were performed as stated in the legends to the figures.
Full Methods and any associated references are available in the online version of the paper.
